Sumeer Dhar

959 total citations
28 papers, 780 citations indexed

About

Sumeer Dhar is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Sumeer Dhar has authored 28 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Sumeer Dhar's work include Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Sumeer Dhar is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Sumeer Dhar collaborates with scholars based in Sweden, Denmark and United States. Sumeer Dhar's co-authors include Rolf Larsson, Peter Nygren, K Csóka, E. Jönsson, Kenneth Nilsson, Rolf Larsson, Anders Isaksson, Mårten Fryknäs, H Fridborg and Joachim Gullbo and has published in prestigious journals such as Nucleic Acids Research, Cancer and Annals of Neurology.

In The Last Decade

Sumeer Dhar

27 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumeer Dhar Sweden 17 450 273 96 85 76 28 780
Lieqi Liu Canada 9 546 1.2× 207 0.8× 49 0.5× 89 1.0× 86 1.1× 9 770
Uttam Pati India 23 641 1.4× 251 0.9× 95 1.0× 229 2.7× 74 1.0× 40 1.1k
Kelly A. Martin United States 12 408 0.9× 241 0.9× 84 0.9× 133 1.6× 65 0.9× 27 762
Eiji Kobayashi Japan 15 589 1.3× 237 0.9× 59 0.6× 95 1.1× 64 0.8× 36 961
Chul-Koo Cho South Korea 18 771 1.7× 194 0.7× 58 0.6× 147 1.7× 97 1.3× 20 1.1k
Sang‐Hyeok Woo South Korea 17 596 1.3× 138 0.5× 50 0.5× 159 1.9× 110 1.4× 21 847
Juxiang Cao United States 12 750 1.7× 178 0.7× 69 0.7× 86 1.0× 142 1.9× 16 972
Toshiya Tamura Japan 19 559 1.2× 233 0.9× 57 0.6× 90 1.1× 66 0.9× 53 969
Irina A. Vasilevskaya United States 17 608 1.4× 219 0.8× 48 0.5× 180 2.1× 58 0.8× 28 904
Kwang-Rok Kim South Korea 12 382 0.8× 199 0.7× 54 0.6× 173 2.0× 42 0.6× 14 692

Countries citing papers authored by Sumeer Dhar

Since Specialization
Citations

This map shows the geographic impact of Sumeer Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumeer Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumeer Dhar more than expected).

Fields of papers citing papers by Sumeer Dhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumeer Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumeer Dhar. The network helps show where Sumeer Dhar may publish in the future.

Co-authorship network of co-authors of Sumeer Dhar

This figure shows the co-authorship network connecting the top 25 collaborators of Sumeer Dhar. A scholar is included among the top collaborators of Sumeer Dhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumeer Dhar. Sumeer Dhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milani, Lili, Manu Gupta, Sumeer Dhar, et al.. (2007). Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Research. 35(5). e34–e34. 50 indexed citations
2.
Fryknäs, Mårten, Sumeer Dhar, Fredrik Öberg, et al.. (2006). STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. International Journal of Cancer. 120(1). 189–195. 53 indexed citations
3.
Orre, Lukas M., Bo Stenerlöw, Sumeer Dhar, et al.. (2006). p53 is involved in clearance of ionizing radiation-induced RAD51 foci in a human colon cancer cell line. Biochemical and Biophysical Research Communications. 342(4). 1211–1217. 12 indexed citations
4.
5.
Rickardson, Linda, Mårten Fryknäs, Sumeer Dhar, et al.. (2005). Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. British Journal of Cancer. 93(4). 483–492. 67 indexed citations
6.
Schulz, Angela, Sumeer Dhar, Svetlana N. Rylova, et al.. (2004). Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Annals of Neurology. 56(3). 342–350. 50 indexed citations
7.
Gullbo, Joachim, Henrik Lövborg, Sumeer Dhar, et al.. (2004). Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828. Anti-Cancer Drugs. 15(1). 45–54. 4 indexed citations
8.
Hassan, Saadia, et al.. (2004). Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 55(1). 47–54. 21 indexed citations
9.
10.
Dhar, Sumeer, Rhonda L. Bitting, Svetlana N. Rylova, et al.. (2002). Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3‐ and CLN2‐deficient neurons. Annals of Neurology. 51(4). 448–466. 60 indexed citations
11.
Dhar, Sumeer, Manuel de la Torre, Agneta Lukinius, et al.. (2001). Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells. European Journal of Cancer. 37(2). 260–267. 21 indexed citations
12.
Jönsson, E., Sumeer Dhar, Bertil Jönsson, et al.. (2000). Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines. European Journal of Cancer. 36(16). 2120–2127. 27 indexed citations
13.
Dhar, Sumeer, Joachim Gullbo, K Csóka, et al.. (2000). Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients. European Journal of Cancer. 36(6). 803–809. 14 indexed citations
14.
Dhar, Sumeer, Peter Nygren, Christer Sundström, et al.. (1998). Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance. European Journal of Pharmacology. 346(2-3). 315–322. 11 indexed citations
15.
Larsson, Rolf, Sumeer Dhar, Hans Ehrsson, Peter Nygren, & Rolf Lewensohn. (1998). Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients. British Journal of Cancer. 78(3). 328–335. 13 indexed citations
16.
Jönsson, E., H Fridborg, K Csóka, et al.. (1997). Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients. British Journal of Cancer. 76(2). 211–219. 38 indexed citations
17.
Dhar, Sumeer, Peter Nygren, K Csóka, et al.. (1996). Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. British Journal of Cancer. 74(6). 888–896. 69 indexed citations
18.
Jönsson, Bertil, K Csóka, H Fridborg, et al.. (1996). Cytotoxic activity of calcein acetoxymethyl ester (calcein/AM) on primary cultures of human haematological and solid tumours. European Journal of Cancer. 32(5). 883–887. 35 indexed citations
19.
Khosa, R. L., et al.. (1996). Investigation on fagonia cretica -its effect on hormonal profile and immunomodulation in rats.. PubMed. 15(4). 259–63. 5 indexed citations
20.
Nygren, Peter, et al.. (1995). Cytotoxic effect of calcein acetoxymethyl ester on human tumor cell lines. Anti-Cancer Drugs. 6(4). 578–585. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lieqi Liu Breakdown of academic impact, for papers by Uttam Pati Breakdown of academic impact, for papers by Kelly A. Martin Breakdown of academic impact, for papers by Eiji Kobayashi Breakdown of academic impact, for papers by Chul-Koo Cho Breakdown of academic impact, for papers by Sang‐Hyeok Woo Breakdown of academic impact, for papers by Juxiang Cao Breakdown of academic impact, for papers by Toshiya Tamura Breakdown of academic impact, for papers by Irina A. Vasilevskaya Breakdown of academic impact, for papers by Kwang-Rok Kim
Rankless by CCL
2026